PA

Prateek Ajmera

Active Director Director DIN 06417040
DIN 06417040 First appointment Jun 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2025
Shareholding value Locked Premium profile

About Prateek Ajmera

Prateek Ajmera has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Pharmaref International Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06417040
Primary Designation Director
First Appointment 26 Jun 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Director 26 Jun 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmaref International Private Limited
Premium access

Shareholding and investment profile for Prateek Ajmera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prateek Ajmera

Prateek Ajmera has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Pharmaref International Private Limited. Engaged in General Business. Contributes to corporate operations.

Prateek Ajmera is associated with 1 company as Director.

Prateek Ajmera has expertise in General Business.

Prateek Ajmera has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available